Status:
UNKNOWN
Accessory Pathway Antegrade Effective Refractory Period Among WPW Patients: the Risk in Relation to the Location
Lead Sponsor:
Assiut University
Conditions:
Wolff-Parkinson-White Syndrome
Eligibility:
All Genders
Brief Summary
To correlate the antegrade effective refractory period of the accessory pathway with its anatomical location in the heart. To investigate whether the accessory pathway location can predict the high r...
Detailed Description
The Wolf-Parkinson-White (WPW) syndrome is a clinical entity characterized by the presence of ≥1 accessory pathways between the atria and the ventricles pre-disposing patients to arrhythmias. Anterogr...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- all patients with WPW admitted to Assuit university hospital and subjected to invasive EPS
- Exclusion criteria:
- heart failure
- cardiomyopathy
Exclusion
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04106622
Start Date
March 1 2020
End Date
March 1 2023
Last Update
January 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.